The Safety and Effectiveness of Low Field Intraoperative MRI Guidance in Frameless Stereotactic Biopsies of Brain Tumours-design and Interim Analysis of a Prospective Randomized Trial

Overview

Journal Neurosurg Rev

Specialty Neurosurgery

Date 2013 Jul 4

PMID 23821131

Citations 10

Authors

M Czyz

P Tabakow

A Weiser

B E Lechowicz-Glogowska

L W Zub

W Jarmundowicz

Affiliations

Soon will be listed here.

Abstract

The aim of the study was to assess the safety and effectiveness of stereotactic brain tumour biopsy (STx biopsy) guided by low-field intraoperative magnetic resonance imaging (iMRI) in comparison with its frameless classic analogue based on a prospective randomized trial. A pilot group of 42 brain tumour patients was prospectively randomized into a low-field iMRI group and a control group that underwent a frameless STx biopsy. The primary endpoints of the analysis were postoperative complication rate and diagnostic yield, and the secondary endpoints were length of hospital stay and duration of operation. The iMRI group (21 patients) and the control group (21 patients) did not differ significantly according to demographic and epidemiological data. No major postoperative complications were noted in either group. In addition, no significant differences in the diagnostic yield (p = 1.00) and length of hospital stay (p = 0.16) were observed. The mean total OR time was 111 ± 24 min in iMRI and 78 ± 29 min in the control group (p = 0.0001). Usage of iMRI may prolong the time of the procedure but seems to be comparable in safety and effectiveness to the standard frameless STx biopsy.

Citing Articles

Comparison meta-analysis of intraoperative MRI-guided needle biopsy versus conventional stereotactic needle biopsies.

Dhawan S, Chen C Neurooncol Adv. 2024; 6(1):vdad129.

PMID: 38187873 PMC: 10771274. DOI: 10.1093/noajnl/vdad129.

Frameless Stereotactic Biopsy with Intraoperative Computed Tomography "Assessment of Efficacy and Real Target Registration Error".

Ikeda N, Katayama Y, Kawabata S, Furuse M, Tsuji Y, Nonoguchi N Neurol Med Chir (Tokyo). 2022; 62(4):195-202.

PMID: 35197401 PMC: 9093670. DOI: 10.2176/jns-nmc.2021-0343.

Efficacy of a Second Brain Biopsy for Intracranial Lesions after Initial Negativity.

Chabaane M, Amelot A, Riche M, Bielle F, Mokhtari K, Carpentier A J Clin Neurol. 2020; 16(4):659-667.

PMID: 33029973 PMC: 7542000. DOI: 10.3988/jcn.2020.16.4.659.

The role of frameless stereotactic biopsy in contemporary neuro-oncology: molecular specifications and diagnostic yield in biopsied glioma patients.

Mader M, Rotermund R, Martens T, Westphal M, Matschke J, Abboud T J Neurooncol. 2018; 141(1):183-194.

PMID: 30390175 DOI: 10.1007/s11060-018-03024-8.

Frameless Stereotactic Insertion of Viewsite Brain Access System with Microscope-Mounted Tracking Device for Resection of Deep Brain Lesions: Technical Report.

White T, Chakraborty S, Lall R, Fanous A, Boockvar J, Langer D Cureus. 2017; 9(2):e1012.

PMID: 28331774 PMC: 5338990. DOI: 10.7759/cureus.1012.

References

Seifert V, Gasser T, Senft C . Low field intraoperative MRI in glioma surgery. Acta Neurochir Suppl. 2010; 109:35-41. DOI: 10.1007/978-3-211-99651-5_6. View

Jain D, Sharma M, Sarkar C, Gupta D, Singh M, Mahapatra A . Comparative analysis of diagnostic accuracy of different brain biopsy procedures. Neurol India. 2006; 54(4):394-8. DOI: 10.4103/0028-3886.28113. View

Isaacs D, Fitzgerald D . Seven alternatives to evidence based medicine. BMJ. 1999; 319(7225):1618. PMC: 28313. DOI: 10.1136/bmj.319.7225.1618. View

Atlas S, Thulborn K . MR detection of hyperacute parenchymal hemorrhage of the brain. AJNR Am J Neuroradiol. 1998; 19(8):1471-7. PMC: 8338682. View

Scholler K, Licht S, Tonn J, Uhl E . Randomized controlled trials in neurosurgery--how good are we?. Acta Neurochir (Wien). 2009; 151(5):519-27. DOI: 10.1007/s00701-009-0280-y. View

Zhong B . How to calculate sample size in randomized controlled trial?. J Thorac Dis. 2012; 1(1):51-4. PMC: 3256489. View

Arle J . Evidence-based medicine: fact or fiction?. World Neurosurg. 2011; 76(1-2):45-7. DOI: 10.1016/j.wneu.2011.06.030. View

Yarascavitch B, Chuback J, Almenawer S, Reddy K, Bhandari M . Levels of evidence in the neurosurgical literature: more tribulations than trials. Neurosurgery. 2012; 71(6):1131-7. DOI: 10.1227/NEU.0b013e318271bc99. View

Han B, Enas N, McEntegart D . Randomization by minimization for unbalanced treatment allocation. Stat Med. 2009; 28(27):3329-46. DOI: 10.1002/sim.3710. View

10.

McGirt M, Woodworth G, Coon A, Frazier J, Amundson E, Garonzik I . Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg. 2005; 102(5):897-901. DOI: 10.3171/jns.2005.102.5.0897. View

11.

Kuker W, Thiex R, Rohde I, Rohde V, Thron A . Experimental acute intracerebral hemorrhage. Value of MR sequences for a safe diagnosis at 1.5 and 0.5 T. Acta Radiol. 2000; 41(6):544-52. DOI: 10.1080/028418500127346180. View

12.

Oken M, Creech R, Tormey D, Horton J, Davis T, McFadden E . Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5(6):649-55. View

13.

Weaver C, Leonardi-Bee J, Bath-Hextall F, Bath P . Sample size calculations in acute stroke trials: a systematic review of their reporting, characteristics, and relationship with outcome. Stroke. 2004; 35(5):1216-24. DOI: 10.1161/01.STR.0000125010.70652.93. View

14.

Baumann F, Schmid C, Bernays R . Intraoperative magnetic resonance imaging-guided transsphenoidal surgery for giant pituitary adenomas. Neurosurg Rev. 2009; 33(1):83-90. DOI: 10.1007/s10143-009-0230-4. View

15.

Senft C, Seifert V, Hermann E, Gasser T . Surgical treatment of cerebral abscess with the use of a mobile ultralow-field MRI. Neurosurg Rev. 2008; 32(1):77-84. DOI: 10.1007/s10143-008-0174-0. View

16.

Hayman L, McArdle C, Taber K, Saleem A, Baskin D, Lee H . MR imaging of hyperacute intracranial hemorrhage in the cat. AJNR Am J Neuroradiol. 1989; 10(4):681-6. PMC: 8332628. View

17.

Schulder M, Carmel P . Intraoperative magnetic resonance imaging: impact on brain tumor surgery. Cancer Control. 2003; 10(2):115-24. DOI: 10.1177/107327480301000203. View

18.

Shooman D, Belli A, Grundy P . Image-guided frameless stereotactic biopsy without intraoperative neuropathological examination. J Neurosurg. 2010; 113(2):170-8. DOI: 10.3171/2009.12.JNS09573. View

19.

Quinn J, Spiro D, Schulder M . Stereotactic brain biopsy with a low-field intraoperative magnetic resonance imager. Neurosurgery. 2011; 68(1 Suppl Operative):217-24. DOI: 10.1227/NEU.0b013e31820826c2. View

20.

Bernays R, Kollias S, Khan N, Brandner S, Meier S, Yonekawa Y . Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging. J Neurosurg. 2002; 97(2):354-62. DOI: 10.3171/jns.2002.97.2.0354. View